These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12667215)

  • 1. A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b.
    Birmingham DJ; Chen W; Liang G; Schmitt HC; Gavit K; Nagaraja HN
    Immunology; 2003 Apr; 108(4):531-8. PubMed ID: 12667215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding.
    Birmingham DJ; Irshaid F; Gavit KF; Nagaraja HN; Yu CY; Rovin BH; Hebert LA
    Mol Immunol; 2007 Jul; 44(14):3510-6. PubMed ID: 17467802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural polymorphisms of complement receptor 1 (CR1) in systemic lupus erythematosus (SLE) patients and normal controls of three ethnic groups.
    Moulds JM; Reveille JD; Arnett FC
    Clin Exp Immunol; 1996 Aug; 105(2):302-5. PubMed ID: 8706338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
    J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35). Analysis based on ligand binding by chimpanzee erythrocyte complement receptor.
    Subramanian VB; Clemenza L; Krych M; Atkinson JP
    J Immunol; 1996 Aug; 157(3):1242-7. PubMed ID: 8757632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
    Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
    J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased frequency of the long (S) allotype of CR1 (the C3b/C4b receptor, CD35) in patients with systemic lupus erythematosus.
    Cornillet P; Gredy P; Pennaforte JL; Meyer O; Kazatchkine MD; Cohen JH
    Clin Exp Immunol; 1992 Jul; 89(1):22-5. PubMed ID: 1352746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune complex binding to erythrocyte-CR1 (CD 35), CR1 expression and levels of erythrocyte-fixed C3 fragments in SLE outpatients.
    Jepsen HH; Møller Rasmussen J; Teisner B; Schrøder L; Holmskov U; Jarlbaek L; Isager H; Svehag SE
    APMIS; 1990 Jul; 98(7):637-44. PubMed ID: 2144431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polymorphism of the C3b/C4b receptor in the normal population and in patients with systemic lupus erythematosus.
    Van Dyne S; Holers VM; Lublin DM; Atkinson JP
    Clin Exp Immunol; 1987 Jun; 68(3):570-9. PubMed ID: 2958190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C3b/C4b receptor (CR1, CD35) on erythrocytes: methods for study of the polymorphisms.
    Cohen JH; Atkinson JP; Klickstein LB; Oudin S; Subramanian VB; Moulds JM
    Mol Immunol; 1999; 36(13-14):819-25. PubMed ID: 10698335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon.
    Kumar A; Kumar A; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
    Immunol Cell Biol; 1995 Oct; 73(5):457-62. PubMed ID: 8595925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients.
    Kisserli A; Schneider N; Audonnet S; Tabary T; Goury A; Cousson J; Mahmoudi R; Bani-Sadr F; Kanagaratnam L; Jolly D; Cohen JH
    Immunobiology; 2021 May; 226(3):152093. PubMed ID: 34022670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited and Acquired Decrease in Complement Receptor 1 (CR1) Density on Red Blood Cells Associated with High Levels of Soluble CR1 in Alzheimer's Disease.
    Mahmoudi R; Feldman S; Kisserli A; Duret V; Tabary T; Bertholon LA; Badr S; Nonnonhou V; Cesar A; Neuraz A; Novella JL; Cohen JHM
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30044434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of C3b receptor (CR1) on erythrocytes of patients with systemic lupus erythematosus contrasts with its normal expression in other systemic diseases and does not correlate with the occurrence or severity of SLE nephritis.
    Jouvin MH; Wilson JG; Bourgeois P; Fearon DT; Kazatchkine MD
    Complement; 1986; 3(2):88-96. PubMed ID: 2945697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene.
    Wilson JG; Wong WW; Murphy EE; Schur PH; Fearon DT
    J Immunol; 1987 Apr; 138(8):2708-10. PubMed ID: 2881967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic insights into complement pathway inhibition by CR1 domain duplication.
    Wymann S; Nair AG; Ewert S; Powers GA; Wan SS; Pelzing M; Baz Morelli A; Rowe T; Hardy MP
    J Biol Chem; 2024 Jul; 300(7):107451. PubMed ID: 38844131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte CR1 (C3b/C4b receptor) levels and disease activity in patients with SLE.
    Thomsen BS; Nielsen H; Andersen V
    Scand J Rheumatol; 1987; 16(5):339-46. PubMed ID: 2961056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No quantitative relationship between CR1 and Lutheran expression on erythrocytes: In(Lu) gene product is not a common regulator of CR1 expression on erythrocytes.
    Oudin S; Lepennec PY; Dervillez X; Tonye-Libyh M; Tabary T; Philbert F; Bougy F; Reveil B; Pennaforte JL; Rouger P; Cohen JH
    Exp Clin Immunogenet; 1999; 16(2):72-80. PubMed ID: 10343158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations.
    Herrera AH; Xiang L; Martin SG; Lewis J; Wilson JG
    Clin Immunol Immunopathol; 1998 May; 87(2):176-83. PubMed ID: 9614933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE).
    Cohen JH; Lutz HU; Pennaforte JL; Bouchard A; Kazatchkine MD
    Clin Exp Immunol; 1992 Mar; 87(3):422-8. PubMed ID: 1531948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.